E Gonca, F Darıcı - Journal of cardiovascular pharmacology …, 2015 - journals.sagepub.com
Cannabidiol (CBD) is a nonpsychoactive phytocannabinoid with anti-inflammatory activity mediated by enhancing adenosine signaling. As the adenosine A1 receptor activation …
The scientific enterprise has long been based on the presumption of replication, although scientists have recently become aware of various corruptions of the enterprise that have hurt …
DA Smiley, RA Khalil - Current medicinal chemistry, 2009 - ingentaconnect.com
The cardiovascular benefits of menopausal hormone therapy (MHT) remain controversial. The earlier clinical observations that cardiovascular disease (CVD) was less common in …
M Davezac, C Meneur, M Buscato, R Zahreddine… - Biochemical …, 2023 - Elsevier
Breast cancer is the most common cancer in women. Over the past few decades, advances in cancer detection and treatment have significantly improved survival rate of breast cancer …
H Zhou, SZ Hou, P Luo, B Zeng, JR Wang… - Journal of …, 2011 - Elsevier
Abstract Ethnopharmacological relevance Ginseng (Panax ginseng CA Meyer) is widely used in Asian communities for treating cardiovascular diseases. However, the mechanism …
RB Penney, D Roy - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2013 - Elsevier
Resistance to endocrine therapy in breast carcinogenesis due to the redox regulation of the signal transduction system by reactive oxygen species (ROS) is the subject of this review …
M Napiórkowska-Mastalerz, T Wybranowski, M Bosek… - Cancers, 2024 - mdpi.com
Simple Summary Breast cancer is the main cause of cancer-related deaths among women globally. It clearly shows it is essential to find a useful marker, which could have a beneficial …
N Pavón, M Buelna-Chontal… - … and Cell Biology, 2019 - cdnsciencepub.com
In the kidney, the accumulation of heavy metals such as Cd2+ produces mitochondrial dysfunctions, ie, uncoupling of the oxidative phosphorylation, inhibition of the electron …
MT Chung, PY Cheng, KK Lam, SY Chen, YF Ting… - Menopause, 2010 - journals.lww.com
Objective: The aim of this study was to investigate the beneficial effect of long-term treatment with raloxifene (RAL), a selective estrogen receptor modulator, on myocardial …